Bladder distension improves the dosimetry of organs at risk during intracavitary cervical high-dose-rate brachytherapy

Bladder distension during cervical brachytherapy significantly reduced dose in all DVH and DSH parameters for sigmoid and small intestine with no change in bladder parameters. It reduces dose to organ at risk, but the correlation to toxicity requires further investigation.